Cat. No. 3119
Biological ActivityNicotinic receptor antagonist that displays selectivity for homomeric α7 and α9 receptors (IC50 values are 220 and 1800 nM respectively). Displays no effect on α2β2, α3β2, α4β2, α2β4, α3β3 and α4β4 subunit combinations.
Licensing InformationSold under license from University of Utah
(Modifications: Cys-12 = C-terminal amide, Disulfide bridge between 2 - 8, 3 - 12)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Pereira et al (1996) α-Conotoxin-ImI: a competitive antagonist at α-Bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons. J.Pharmacol.Exp.Ther. 278 1472. PMID: 8819535.
Johnson et al (1995) α-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric α7 and α9 receptors. Mol.Pharmacol. 48 194. PMID: 7651351.
McIntosh et al (1994) A nicotinic acetylcholine receptor ligand of unique specificity, α-conotoxin ImI. J.Biol.Chem. 269 16733. PMID: 8206995.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses α-Conotoxin ImI from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: a-conotoxin ImI, supplier, α7, alpha7, a7, α9, alpha9, a9, selective, nAChR, antagonists, Nicotinic, Receptors, Acetylcholine, Non-Selective, Subtypes, Other, α-conotoxin, alpha-conotoxin, ImI, a-conotoxinImI, conotoxin, Tocris Bioscience, Nicotinic (α7) Receptor Antagonist products
Find multiple products by catalog number
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.